Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries
Étienne Puymirat(Inserm), Jean Ferrières(Université Fédérale de Toulouse Midi-Pyrénées), Grégory Ducrocq, Nicolas Danchin(Assistance Publique – Hôpitaux de Paris), Victoria Tea(Assistance Publique – Hôpitaux de Paris), Guillaume Cayla(Centre Hospitalier Universitaire de Nîmes), Maxime Fumery(Assistance Publique – Hôpitaux de Paris), Laurent Bonello(Assistance Publique Hôpitaux de Marseille), Gilles Lemesles, Tabassome Simon(Sorbonne Université), Marc P. Bonaca(The Medical Center of Aurora), Nadia Aïssaoui(Université Paris Cité), François Schiele(Centre Hospitalier Universitaire de Besançon)
Cited by 20
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k
Rivaroxaban in Peripheral Artery Disease after Revascularization
|New England Journal of Medicine|2020|966
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
|New England Journal of Medicine|2012|941